Japan and the US just co-signed the yen

Caterpillar's earnings this week land in the middle of an AI selloff that has nothing to do with excavators and everything to do with whether data centre construction demand, which has been propping up Caterpillar's power generation and construction equipment orders, keeps growing at the pace hyperscalers promised. The 439% return investors piled into after last year's 'situational awareness' AI infrastructure thesis is now the thing being tested in real time: if AI capex slows even modestly, industrial suppliers feel it before the chipmakers do, because equipment orders get cancelled months ahead of GPU orders. Monetising AI at the application layer remains genuinely hard, with most enterprise deployments still running on subsidised compute rather than profitable unit economics, which is the tension nobody selling picks-and-shovels stocks wants repriced. Caterpillar's order book commentary this week will tell investors more about AI capex durability than any hyperscaler earnings call has.

Anduril moving into physical shipyard capacity, rather than just software and munitions, is the clearest sign yet that the defence tech firm sees autonomous naval systems as a manufacturing problem, not a prototyping one. A Baltimore investment would put Anduril in direct competition with legacy shipbuilders like Huntington Ingalls for Navy contracts, except Anduril's pitch is speed and unit cost rather than tonnage. The US Navy's stated appetite for unmanned surface vessels has outpaced traditional shipyards' willingness to retool for smaller, software-heavy hulls, leaving an opening Anduril is moving fast to fill before the Pentagon locks in a different primary contractor.

SpaceX has never had to answer public-market-style earnings questions, and the timing here is brutal: its first real scrutiny arrives days before roughly $100bn of employee and early-investor stock becomes freely tradeable, which means any wobble in Starlink subscriber growth or Starship cadence gets amplified by sellers looking to finally cash out. Starlink now accounts for the majority of SpaceX revenue by most private estimates, well ahead of launch services, which makes this less a rocket company story and increasingly a satellite broadband one competing directly with Amazon's Kuiper. A soft print doesn't sink SpaceX's valuation on its own, but it gives insiders sitting on a decade of paper gains a very good reason to sell into strength rather than wait for the next lockup.

HSBC shares have run further than most UK bank analysts expected this year, which means Wednesday's numbers face a higher bar than a simple beat, they need to justify a valuation that's already priced in an Asia recovery story that hasn't fully materialised. Korean firms loading up on short-term debt funding ahead of the recent market rout is the more uncomfortable data point buried in the same news cycle: it means Korean corporates were caught rolling cheap short-dated paper right as volatility spiked, a funding mismatch that tends to surface as forced asset sales rather than headlines, until it doesn't. Separately, TMX's push into ASX with a tech-first strategy against Cboe is a reminder that exchange competition in Asia-Pacific is intensifying at exactly the moment liquidity is getting more fragile, not less.

KKR's $4.3bn purchase of Integer Holdings, a medical device components maker, lands the same week Lantheus Holdings agrees to be acquired for an initial $6.7bn, and together they confirm that healthcare infrastructure and diagnostics, not biotech pipelines, are where big capital wants exposure right now. Integer supplies components into cardiac and neuromodulation devices for the likes of Medtronic and Abbott, giving KKR a picks-and-shovels position in a device market growing faster than pharma. Lantheus, meanwhile, makes its money on radiopharmaceutical diagnostics tied to Alzheimer's and cancer imaging, a segment insulated from the patent-cliff risk hammering traditional pharma valuations. Both deals price in double-digit premiums, and both bidders are betting stable, recurring device and diagnostics revenue outlasts patience for binary drug trial outcomes.

Zara, H&M and their peers launching resale arms isn't about sustainability credentials, it's about owning the customer twice: once at first sale and again when that same item resurfaces on a platform they control, rather than ceding that transaction to Vinted or Depop entirely. The economics only work if brands can capture resale volume without cannibalising new sales, which is why most of these programmes are structured as store credit rather than cash, keeping the customer inside the brand's retail loop. Depop and Vinted's user growth over the past three years is the real pressure forcing this move, not consumer demand for corporate virtue. The brands that win here are the ones treating resale as inventory management, not marketing.

Marriott flagging that the Middle East conflict weighed on sales confirms what airlines have been saying for months quietly: regional conflict is now a line item in hospitality earnings, not a footnote. Gulf and broader Middle East travel demand has been a genuine growth engine for major hotel groups over the past five years, so any pullback there hits disproportionately against a base that was supposed to be the offset to soft Western consumer spending. Marriott's exposure runs through both leisure bookings and, more importantly, corporate and MICE travel, the higher-margin segment that dries up fastest when clients start rerouting delegations. Rivals with less regional concentration, Hilton and IHG among them, are the relative winners simply by being less exposed.

Organised labour's next target after grocery and warehouse workers is the gig economy, and Uber's driver base is the biggest single pool to organise given the scale of its US and UK operations. Uber has spent a decade and hundreds of millions of pounds in legal fees defending the classification line between contractor and employee, and every successful unionisation push elsewhere in the gig sector chips away at the precedent Uber relies on. The UK's own gig worker rulings, following the 2021 Supreme Court decision granting minimum wage and holiday pay to Uber drivers, already narrowed that gap here more than in most US states. Any renewed union push forces Uber to choose between fighting a multi-jurisdiction legal war or renegotiating driver economics that currently keep its margins thin but positive.

The government's extension of the 16-17 Saver-style discount to 18-year-olds is a modest fiscal move, but it lands at a time when rail operators are already under pressure to prove ridership recovery post-pandemic holds without further fare cuts eating into revenue. Train operating companies get compensated by the Department for Transport for lost fare revenue under these schemes, meaning the cost sits with taxpayers, not TOCs, which is exactly why this kind of discount is politically easy to extend and hard to reverse once young voters expect it permanently.

This is the latest tranche under borrower defense to repayment rules, the mechanism that lets defrauded students at collapsed for-profit colleges get federal loans discharged, and 170,000 more approvals adds meaningfully to the multi-billion-dollar total already forgiven since the programme's expansion. The pattern here matters for anyone tracking US student debt as a macro drag: each wave of discharges reduces outstanding federal loan balances without touching the underlying for-profit college accountability problem that created the fraud in the first place. Expect the same institutions' former students to keep filing claims in future rounds.

Creditors are pushing back on a plan to sell off Aston Martin branding rights, a sign the carmaker's balance sheet repair is running into resistance from the people it owes money to, not just the market.

The doubling came almost entirely from paper gains on its MGM investment, not operating performance, worth remembering before anyone extrapolates the print into a trend.

Snap's path to profitability still runs through headcount reduction rather than ad revenue reacceleration, which tells you where Wall Street's patience actually sits.

Cyclospora outbreaks are typically linked to contaminated fresh produce imports, making this a supply chain traceability problem for grocers and importers as much as a public health one.

KKR now owns a supplier feeding directly into Medtronic and Abbott device lines, a quieter but stickier bet than the diagnostics deals grabbing headlines this week.